NASDAQ · Healthcare · Biotechnology

Cytokinetics, Incorporated

CYTK

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. CEO Robert I. Blum · Market cap $7.7B.

$62.01

+0.89 · +1.46%

52w hi $88.3152w lo $54.30

Off 52w high 21.5%

ROUTINE

Current InsiderScore

Corp · 90d

0 buys · 2 sales

Cong · 90d

0 buys · 0 sales

Signals ≥ 60 · 12mo

0 strong · 0 notable

Analyst consensus

Strong Buy

Avg PT $112.50

Section 01

Recent Form 4 filings

11 filings on file

Date	Insider	Role	Action	Shares	Price	Value	Score
Sep 15	Robert I Blum	President & CEO	Sell	97,926	$69.33	−$6.79M	53
Jul 30	Andrew Callos	EVP, Chief Commercial Officer	Sell	14,000	$79.88	−$1.12M	30
Jul 01	Andrew Callos	EVP, Chief Commercial Officer	Sell	15,000	$85.80	−$1.29M	30
Jun 24	Sung Lee	EVP, Chief Financial Officer	Sell	38,730	$82.30	−$3.19M	38
May 05	John T Henderson		Sell	20,000	$75.97	−$1.52M	28
May 05	Sung Lee	EVP, Chief Financial Officer	Sell	23,906	$76.87	−$1.84M	38
May 01	Andrew Callos	EVP, Chief Commercial Officer	Sell	15,857	$65.00	−$1.03M	30
Mar 17	Robert I Blum	President & CEO	Sell	23,928	$62.15	−$1.49M	34
Dec 22	Wendell Wierenga		Sell	20,000	$66.14	−$1.32M	32
Dec 05	Andrew Callos	EVP, Chief Commercial Officer	Sell	52,486	$65.95	−$3.46M	37
Dec 01	Edward M. Kaye MD		Sell	28,064	$66.72	−$1.87M	35

Section 02

Recent STOCK Act disclosures

1 disclosures on file

Disclosed	Legislator	Chamber · State	Action	Range	Midpoint	Delay	Score
Jul 03	Gilbert Cisneros	House · CA	Buy	$1,001 - $15,000	$8K	3 d	51

Section 03

InsiderScore history

Rolling 12 months · peak score per month

NovDecJanFebMarAprMayJunJulAugSepOct